Metallothionein: a game changer in histopathological diagnosis of Wilson disease

Aims Wilson disease (WD) is a genetic disorder of copper metabolism caused by mutations in the ATP7B gene. Toxic copper accumulation leads to hepatic, neurologic, and psychiatric disorders with variable presentation. Metallothionein (MT) immunohistochemistry was proposed as a diagnostic marker. Meth...

Full description

Saved in:
Bibliographic Details
Main Authors: Wiethoff, Hendrik (Author) , Mohr, Isabelle (Author) , Fichtner, Alexander (Author) , Merle, Uta (Author) , Schirmacher, Peter (Author) , Weiss, Karl Heinz (Author) , Longerich, Thomas (Author)
Format: Article (Journal)
Language:English
Published: December 2023
In: Histopathology
Year: 2023, Volume: 83, Issue: 6, Pages: 936-948
ISSN:1365-2559
DOI:10.1111/his.15041
Online Access:Verlag, kostenfrei, Volltext: https://doi.org/10.1111/his.15041
Verlag, kostenfrei, Volltext: https://onlinelibrary.wiley.com/doi/abs/10.1111/his.15041
Get full text
Author Notes:Hendrik Wiethoff, Isabelle Mohr, Alexander Fichtner, Uta Merle, Peter Schirmacher, Karl H Weiss & Thomas Longerich
Description
Summary:Aims Wilson disease (WD) is a genetic disorder of copper metabolism caused by mutations in the ATP7B gene. Toxic copper accumulation leads to hepatic, neurologic, and psychiatric disorders with variable presentation. Metallothionein (MT) immunohistochemistry was proposed as a diagnostic marker. Methods MT immunohistochemistry was performed on liver specimens of WD patients (n = 64) and control cases (n = 160) including acute liver failure, steatotic liver disease, autoimmune hepatitis, normal liver, primary biliary cholangitis, primary and secondary sclerosing cholangitis, and progressive familial intrahepatic cholestasis. The optimal cutoff for detection of WD was determined by receiver operating characteristic (ROC) analysis. Results At least moderate staining in >50% of hepatocytes was observed in 81% of analysed liver specimens (n = 56/69) of WD patients, while only five control cases showed this staining pattern. The sensitivity, specificity, and accuracy for a new diagnosis of WD were 85.7%, 96.9%, and 94.9%, respectively. Sensitivity in nonfibrotic patients was 70.6% and this MT pattern was robust in small biopsies. The hepatic copper concentration was similar between MT-positive and MT-negative liver samples (P > 0.05). Zinc treatment may induce hepatocellular MT expression. Kayser-Fleischer rings (50% versus 15%) and neurologic disorders (50% versus 13%) were significantly more prevalent in MT-negative compared to MT-positive WD patients, respectively. Conclusion MT immunostaining is an excellent biomarker for histological diagnosis of WD, should be incorporated in the diagnostic work-up of patients with potential WD, and is useful in a modified Leipzig score.
Item Description:Online veröffentlicht: 04. September 2023
Gesehen am 25.10.2023
Physical Description:Online Resource
ISSN:1365-2559
DOI:10.1111/his.15041